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Decrease of cholesterol in mouse melanoma causes secretion of
lysosomal enzymes
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ABSTRACT? We examined the change in the subcellular distribution of a lysosomal 
enzyme, ?-glucuronidase (?-G), caused by decreased cholesterol levels in mouse melanoma 
cells using a HMG-CoA reductase inhibitor, lovastatin, and lipoprotein-deficient serum 
(LDS).  There was a decrease in the cholesterol content of the cells and increased secretion 
of the mature form of ?-G located in lysosomes, as documented by Percoll density gradient 
fractionation, digitonin permeabilization, and immunoprecipitation.  Furthermore, another 
lysosomal enzyme, cathepsin H, was found to be released in the medium from cells treated 
with lovastatin.  Both the precursor and mature forms of cathepsin H were detected in 
the medium of treated cells.  Next, when cells were treated with LDS without lovastatin, 
concomitantly with the decrease in the levels of cholesterol and ?-G activity in the cells,??-G 
activity in the medium increased.  Also, the ratio of ?-G (3.2-fold) released in the medium 
from cells treated with D-MEM containing lovastatin and LDS was higher than that (2.3-fold) 
on treatment with D-MEM containing LDS without lovastatin.  From these results, it was 
suggested that the exocytosis of mature enzymes from lysosomes into the medium or mis-
sorting of the lysosomal precursor forms to the medium was caused by the lovastatin- and/or 
LDS-induced decrease in the cholesterol content of the cells, although the mechanism of 
secretion by lysosomal enzymes differed somewhat.
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